Skip to content
Publication

Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH

International Journal of Molecular Sciences 22:6332, 2021

Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top